If you’ve turned on a TV or scrolled through social media lately, you’ve seen the buzz around medications like Ozempic, Wegovy, and Mounjaro. For many folks, these drugs are life-changing, but the biggest question we get at The Gonzales Agency is: “Will my Medicare plan actually pay for it?”
The answer for 2026 is: It depends on the "Why."
The Golden Rule of 2026 Coverage
Medicare is still prohibited by federal law from covering drugs used solely for weight loss. However, the rules for "related conditions" have expanded significantly this year.
- Diabetes Coverage: Ozempic and Mounjaro are generally covered by Part D when prescribed for Type 2 Diabetes.
The Power of "Prior Authorization"
Even if a drug is on your plan's list, insurance companies in 2026 are using Prior Authorization more than ever. This means your doctor needs to submit the correct paperwork—showing your history of heart issues, BMI, or diabetes—so the pharmacy doesn't hit you with a "denied" message at the counter.
How The Gonzales Agency Helps
Navigating these "formularies" (drug lists) is what we do best. During our 2026 reviews, we check your specific medications against every available plan to see which plans offer the lowest copays for your specific brand.
The rules are changing fast, but you don't have to figure them out alone. Join our next webinar where we’ll dive deep into Medicare in 2026
Click Here to Register for the Next Webinar
TPMO Disclaimer: We do not offer every plan available in your area. Please contact Medicare.gov, 1‑800‑MEDICARE, or your local State Health Insurance Program (SHIP) to get information on all of your options.
